Biological activities and Chemical moieties as Scaffold for the design of Pharmacological lead compounds for Alzheimer's disease

Author:

Sharma Divya1,Singh Akanksha1,Gupta Himanshu1,Sharma Diksya1,Singh Pooja1,Singh Arjun2

Affiliation:

1. Department of Pharmacognosy, School of Pharmaceutical Sciences, Bhagwant University, Sikar Road, Ajmer, Rajasthan 305004, India.

2. Department of Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, United States.

Abstract

Alzheimer's disease (AD) is a major problem in today's societies. More than five million Americans are living with Alzheimer's disease in the United States, with the majority being 65 and older. According to the Alzheimer's Association Report, the number of persons affected by Alzheimer's disease in the United States would rise to fourteen million by 2060.Alzheimer's disease (AD) is a neurodegenerative disorder characterized by impaired synaptic transmission and brain atrophy, as well as the formation of amyloid plaques and neurofibrillary tangles. The condition is usually associated with cognitive, functional, and behavioural changes. Several pathophysiological paths for Alzheimer's disease have been hypothesized, some of which interact and influence one another. Current Alzheimer's disease treatment focuses on using therapeutic drugs to reduce symptoms in Alzheimer's patients. Because of the disease's complex nature, standard single-target therapeutic techniques frequently fail to have the desired impact. As a result, multi-target methods have been developed, with the goal of simultaneously targeting various targets involved in the development of AD. This paper provides an outline of the pathophysiology of Alzheimer's disease and current pharmacological therapy.

Publisher

A and V Publications

Reference37 articles.

1. Chanda, Debrabata, Jesus Prieto-Lloret, Arjun Singh, Hina Iqbal, Pankaj Yadav, Vladimir Snetkov, and Philip I Aaronson. Glabridin-Induced Vasorelaxation: Evidence for a Role of BKCa Channels and Cyclic GMP. Life Sciences. 2016; 165: 26–34. https://doi.org/10.1016/j.lfs.2016.09.018.

2. Gautam, Yashveer, Sonam Dwivedi, Ankita Srivastava, Hamidullah, Arjun Singh, D. Chanda, Jyotsna Singh, Smita Rai, Rituraj Konwar, and Arvind S. Negi. 2-(3′,4′-Dimethoxybenzylidene) Tetralone Induces Anti-Breast Cancer Activity through Microtubule Stabilization and Activation of Reactive Oxygen Species. RSC Advances. 2016; 6(40): 33369–79. https://doi.org/10.1039/C6RA02663J.

3. Hamid, A.A., Mohammad Hasanain, Arjun Singh, Balakishan Bhukya, Omprakash, Prema G. Vasudev, Jayanta Sarkar, et al. Synthesis of Novel Anticancer Agents through Opening of Spiroacetal Ring of Diosgenin. Steroids. 2014; 87: 108–18. https://doi.org/10.1016/j.steroids.2014.05.025.

4. Hamid, A.A., Tanu Kaushal, Raghib Ashraf, Arjun Singh, Amit Chand Gupta, Om Prakash, Jayanta Sarkar, et al. (22β,25R)-3β-Hydroxy-Spirost-5-En-7-Iminoxy-Heptanoic Acid Exhibits Anti-Prostate Cancer Activity through Caspase Pathway. Steroids. 2017; 119: 43–52. https://doi.org/10.1016/j.steroids.2017.01.001.

5. Jain, Shilpi, Arjun Singh, Puja Khare, D. Chanda, Disha Mishra, Karuna Shanker, and Tanmoy Karak. Toxicity Assessment of Bacopa Monnieri L. Grown in Biochar Amended Extremely Acidic Coal Mine Spoils. Ecological Engineering. 2017; 108: 211–19. https://doi.org/10.1016/j.ecoleng.2017.08.039.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3